0001968582-24-000687.txt : 20240812 0001968582-24-000687.hdr.sgml : 20240812 20240812162318 ACCESSION NUMBER: 0001968582-24-000687 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240812 DATE AS OF CHANGE: 20240812 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 241197112 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ber Gerard CENTRAL INDEX KEY: 0001762144 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O Y-MABS THERAPEUTICS, INC. STREET 2: 230 PARK AVENUE, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10169 144 1 primary_doc.xml 144 0001762144 XXXXXXXX LIVE 0001521036 Lantheus Holdings, Inc. 001-36569 331 Treble Cove Road North Billerica MA 01862 978-671-8001 Gerard Ber Director Common Shares J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

15500 1508615 69430642 08/12/2024 NASDAQ Common Shares 06/19/2020 Conversion of Progenics shares into Lantheus shares post merger Issuer N 15500 06/19/2020 N/A Y 08/12/2024 05/07/2024 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Gerard Ber